NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells

Journal of Cellular Biochemistry

Volumn 95, Issue 1, 2005, Pages 64-73

  Wang, Lili ^a,b   Ma, Jian ^a   Li, Jiang ^a   Li, Xiaoling ^a   Zhang, Qiuhong ^a   Peng, Shuping ^a   Peng, Cong ^a   Zhou, Ming ^a   Xiong, Wei ^a   Yang, Jianbo ^a   Zhou, Jie ^a   Fan, Songqing ^a   Tan, Chen ^a   Yan, Qun ^c   Shen, Shourong ^b   Li, Guiyuan ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

EGF like domain; EGFR; Nasopharyngeal carcinoma; NGX6

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAS PROTEIN; CYCLIN D; CYCLINE; MEMBRANE PROTEIN; NGX6 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHINA; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE ISOLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOUSE; NASOPHARYNX CARCINOMA; NGX6 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; RARE DISEASE; STATISTICAL SIGNIFICANCE; TUMOR VOLUME; ANIMAL; BIOSYNTHESIS; CARCINOMA; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; NUDE MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLINS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, EXPERIMENTAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 23844488522     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20393     Document Type: Article

References (30)

1. Aaronson SA. 1991. Growth factors and cancer. Science 254(5035):1146-1153.
2. Bergmann A, Tugentman M, Shilo BZ, Steller H. 2002. Regulation of cell number by MAPK-dependent control of apoptosis: A mechanism for trophic survival signaling. Dev Cell 2(2):159-170.
3. Chen YJ, Ko JY, Chen PJ, Shu CH, Hsu MT, Tsai SF, Lin CH. 1999. Chromosomal aberrations in nasophayngeal carcinoma analysed by comparative genomic hybridization. Genes Chromosomes Cancer 25:169-175.
4. Chien G, Yuen PW, Kwong D, Kwong YL. 2001. Comparative genomic hybridization analysis of nasopharyngeal carcinoma: Consistent patterns of genetic aberrations and clinicopathological correlations. Cancer Genet Cytogenet 126:63-67.
5. Esparis-Ogando A, Diaz-Rodriguez E, Montero JC, Yuste L, Crespo P, Pandiella A. 2002. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol 22(1):270-285.
6. Fan CS, Wong N, Leung SF, To KF, Lo KW, Lee SW, Mok TS, Johnson PJ, Huang DP. 2000. Frequent c-myc and Int-2 over-representations in nasopharyngeal carcinoma. Hum Pathol 31:169-178.
7. Fang Y, Guan XY, Quo Y, Sham JST, Deng M, Liang Q, Li H, Zeng H, Zhou H, Trent J. 2001. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Gense Chromosomes Cancer 30:254-260.
8. Huang DP, Lo KW, van Hasselt CA, Woo JKS, Choi PHK, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JCK. 1994. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 54:4003-4006.
9. Hui ABT, Lo KW, Leung SF, Teo P, Fung MKF, To KF, Wong N, Choi PHK, Lee JCK, Huang DP. 1999. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 82:498-503.
10. Kanno N, Lesage G, Phinizy JL, Glaser S, Francis H, Alpini G. 2002. Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. Hepatology 35(6):1329-1340.
11. Kerkhoff E, Rapp UR. 1998. Cell cycle targets of Ras/Raf signalling. Oncogene 17(11):1457-1462.
12. Lee JT, Jr., McCubrey JA. 2002. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16(4):486-507.
13. Li S, Couvillon AD, Brasher BB, Van Etten RA. 2001. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: A novel regulatory mechanism for tyrosine kinase signaling. EMBO J 20(23):6793-6804.
14. Lo KW, Teo PM, Hui AB, To KF, Tsang YS, Chan SY, Mak KF, Lee JC, Huang DP. 2000. High-resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 60:3348-3353.
15. Lopez-Ilasaca M. 1998. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 56(3):269-277.
16. Maida Y, Kyo S, Kanaya T, Wang Z, Yatabe N, Tanaka M, Nakamura M, Ohmichi M, Gotoh N, Murakami S, Inoue M. 2002. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 21(26):4071-4079.
17. Motohashi T, Miyoshi S, Osawa M, Eyre HJ, Sutherland GR, Matsuda Y, Nakamura Y, Shibuya A, Iwama A, Nakauchi H. 2000. Molecular cloning and chromosomal mapping of a novel five-span transmembrane protein gene, M83. Biochem Biophys Res Commun 276:244-250.
18. Mutirangura A, Tanunyuthawongese C, Pornthanakasem W, Kerekhanjanarong V, Sriuranpong V, Yenrudi S, Supiyaphun P, Voravud N. 1997. Genomic alterations in nasopharyngeal carcinoma:loss of heterozygosity and Epstein-Barr virus infection. Br J Cancer 76:770-776.
19. Parkin DM, Muir CS. 1992. Cancer incidence in five continents: Comparability and quality of data. IARC Sci Publ 120:451-473.
20. Peyssonnaux C, Eychene A. 2001. The Raf/MEK/ERK pathway: New concepts of activation. Biol Cell 93(1-2): 53-62.
21. Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova IV, Martinez J, Larcher F, Slaga TJ, Gutkind JS, Jorcano JL, Paramio JM. 2002. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21(1):53-64.
22. Shao JY, Wang HY, Huang XM, Feng QS, Huang P, Feng BJ, Huang LX, Yu XJ, Li JT, Hu LF, Ernberg I, Zeng YX. 2000. Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int J Oncol 17:1267-1275.
23. Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL, Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, Hu LF, Zeng YX. 2001. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Anticancer Res 21:3021-3029.
24. Simons MJ, Wee GB, Singh D, Dharmalingham S, Yong NK, Chau JC, Ho JH, Day NE, De The G. 1977. Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2) associated with an increased risk in Chinese for nasopharyngeal carcinoma. Natl Cancer Inst Monogr 47:147-151.
25. Strelkov IS, Davie JR. 2002. Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts. Cancer Res 62(1):75-78.
26. Sun Y, Fry DW, Vincent P, Nelson JM, Elliott W, Leopold WR. 1999. Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors. Anticancer Res 19(2A):919-924.
27. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM. 1999. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 59(16):4083-4089.
28. Wong N, Hui AB, Fan B, Lo KW, Pang E, Leung SF, Huang DP, Johnson PJ. 2003. Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. Cancer Genet Cytogenet 140(2): 124-132.
29. Yang JB, Bin LH, Li ZH, Zhang XH, Qian J, Zhang BC, Zhou M, Xie Y, Deng LW, Li GY. 2000. Refined localization and cloning of a novel putative tumor suppressor gene associated with nasopharyngeal carcinoma on 9p21-22. China J Cancer 19(1):6-9.
30. Yao KT, Zhang HY, Zhu HC, Wang FX, Li GY, Wen DS, Li YP, Tsai CH, Glaser R. 1990. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int J Cancer 45:83-89.